Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
Inventory
Atara Biotherapeutics Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Inventory
$16.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$8.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$813.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
54%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
41%
|
See Also
What is Atara Biotherapeutics Inc's Inventory?
Inventory
16.1m
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Inventory amounts to 16.1m USD.
What is Atara Biotherapeutics Inc's Inventory growth rate?
Inventory CAGR 1Y
203%
Over the last year, the Inventory growth was 203%.